Schrodinger (NASDAQ:SDGR) EVP Yvonne Tran Sells 32,000 Shares of Stock

Key Points

• Schrödinger EVP Yvonne Tran sold 32,000 shares for about $1.05 million at an average price of $32.85, reducing her direct stake by 37.79% to 52,683 shares. The sale was made under a pre-arranged Rule 10b5-1 trading plan.
• The company’s latest quarter beat analyst expectations: loss per share was $0.50 versus a forecast loss of $0.67, while revenue of $64.49 million exceeded the $47.73 million consensus and rose 18.7% year over year.
• Analysts’ consensus rating was Hold, with an average price target of $26.67. Shares traded at $32.41 in Tuesday midday trading, below the reported 52-week high of $33.78.

Schrodinger, Inc. (NASDAQ:SDGR - Get Free Report) EVP Yvonne Tran sold 32,000 shares of the stock in a transaction on Monday, November 9th. The shares were sold at an average price of $32.85, for a total value of $1,051,200.00. Following the sale, the executive vice president directly owned 52,683 shares in the company, valued at approximately $1,730,636.55. The trade was a 37.79% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Schrodinger Stock Performance

Schrodinger stock traded down $0.98 during midday trading on Tuesday, reaching $32.41. 1,714,603 shares of the company were exchanged, compared to its average volume of 1,554,629. The firm's 50-day simple moving average is $26.07 and its 200-day simple moving average is $17.16. Schrodinger, Inc. has a 1 year low of $10.94 and a 1 year high of $33.78. The company has a market capitalization of $2.39 billion, a price-to-earnings ratio of -41.02 and a beta of 1.69.

Schrodinger (NASDAQ:SDGR - Get Free Report) last released its quarterly earnings results on Wednesday, November 4th. The company reported ($0.50) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.67) by $0.17. The company had revenue of $64.49 million for the quarter, compared to analysts' expectations of $47.73 million. Schrodinger had a negative net margin of 22.02% and a negative return on equity of 17.66%. The firm's revenue for the quarter was up 18.7% compared to the same quarter last year. During the same period last year, the company earned ($0.45) EPS. On average, analysts forecast that Schrodinger, Inc. will post -1.39 EPS for the current fiscal year.

Hedge Funds Weigh In On Schrodinger

Institutional investors and hedge funds have recently bought and sold shares of the stock. BlackRock Inc. purchased a new position in Schrodinger in the 2nd quarter valued at about $170,978,000. Rubric Capital Management LP lifted its stake in shares of Schrodinger by 43.8% in the first quarter. Rubric Capital Management LP now owns 6,000,000 shares of the company's stock worth $68,160,000 after acquiring an additional 1,828,502 shares in the last quarter. Amova Asset Management Americas Inc. boosted its holdings in Schrodinger by 13.2% in the first quarter. Amova Asset Management Americas Inc. now owns 3,190,837 shares of the company's stock valued at $36,248,000 after purchasing an additional 371,167 shares during the last quarter. Public Sector Pension Investment Board boosted its holdings in Schrodinger by 79.0% in the third quarter. Public Sector Pension Investment Board now owns 350,738 shares of the company's stock valued at $10,890,000 after purchasing an additional 154,824 shares during the last quarter. Finally, Bank of New York Mellon Corp purchased a new position in Schrodinger in the second quarter valued at about $4,986,000. Hedge funds and other institutional investors own 79.05% of the company's stock.

Analyst Ratings Changes

A number of analysts have recently commented on SDGR shares. KeyCorp upped their price objective on Schrodinger from $20.00 to $32.00 and gave the stock an "overweight" rating in a report on Friday, October 16th. Wall Street Zen raised Schrodinger from a "strong sell" rating to a "hold" rating in a research report on Saturday, August 8th. BMO Capital Markets upped their price target on Schrodinger from $24.00 to $30.00 and gave the stock an "outperform" rating in a research note on Monday, October 12th. Weiss Ratings upgraded Schrodinger from a "sell (e+)" rating to a "sell (d-)" rating in a report on Thursday, August 27th. Finally, Zacks Research lowered Schrodinger from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, November 3rd. Four research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $26.67.

About Schrodinger

Schrödinger, Inc. develops computational software used to support drug discovery and materials research. Its platform applies physics-based modeling, computational chemistry and machine learning to help researchers analyze molecular properties and identify promising candidates. The company's tools are used by pharmaceutical and biotechnology companies, academic institutions and other research organizations. Alongside software sales and subscriptions, Schrödinger works with partners on drug discovery programs and advances a portfolio of its own therapeutic candidates.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.